Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023
Profit After Tax
YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023
Compare Profit and Loss Results of Fredun Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
348.00
549.00
-201.00
-36.61%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
348.00
549.00
-201.00
-36.61%
Expenditure (Ex Depriciation)
Stock Adjustments
-22.00
-10.00
-12.00
-120.00%
Raw Materials Consumed
282.00
295.00
-13.00
-4.41%
Power & Fuel Cost
4.00
13.00
-9.00
-69.23%
Employee Cost
12.00
115.00
-103.00
-89.57%
Operating Expenses
10.00
36.00
-26.00
-72.22%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
51.00
-46.00
-90.20%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
13.00
-12.00
-92.31%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
310.00
562.00
-252.00
-44.84%
Operating Profit (PBDIT) excl Other Income
37.00
-12.00
49.00
408.33%
Other Income
0.00
81.00
-81.00
-100.00%
Operating Profit (PBDIT)
38.00
68.00
-30.00
-44.12%
Interest
13.00
2.00
11.00
550.00%
Profit before Depriciation and Tax
25.00
65.00
-40.00
-61.54%
Depreciation
3.00
24.00
-21.00
-87.50%
Profit Before Taxation & Exceptional Items
21.00
40.00
-19.00
-47.50%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
21.00
264.00
-243.00
-92.05%
Provision for Tax
5.00
8.00
-3.00
-37.50%
Profit After Tax
15.00
256.00
-241.00
-94.14%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
-398.00
426.00
107.04%
Profit Available for appropriations
44.00
-142.00
186.00
130.99%
Appropriations
44.00
-142.00
186.00
130.99%
Equity Dividend (%)
7%
0%
7.00
Earnings Per Share
33.66
38.08
-4.42
-11.61%
Profit And Loss - Net Sales
Net Sales 348.16 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.98 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023
Profit And Loss - Interest
Interest 13.65 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023
Profit And Loss - Profit After Tax
Profit After Tax 15.62 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023






